Christi Shaw

Christi Shaw is a prominent figure in the biopharmaceutical industry, currently serving on the Dean’s Advisory Council at Iowa State University’s Ivy College of Business. She holds a bachelor's degree in business administration from Iowa State University and has extensive experience in leadership roles across various companies.

Professional Background

• Current Role: Christi Shaw is the former Chief Executive Officer of Kite, a Gilead company specializing in CAR T-cell therapy, where she led efforts to advance cancer treatment and significantly increased patient outreach.12
• Previous Experience: She has held senior positions at Eli Lilly & Co., Novartis, and Johnson & Johnson, contributing to her reputation as a thought leader in the biopharmaceutical sector.23
• Board Memberships: Christi serves on several boards, including Avantor and the Healthcare Businesswomen’s Association (HBA), and is involved with the Biotechnology Innovation Organization (BIO).1

Recognition

Shaw has received multiple accolades for her contributions to healthcare and leadership, including:

• Lifetime Achievement Award from Eye for Pharma (2016)
• Woman of the Year by the Healthcare Businesswomen's Association (2023)
• Featured in Forbes 50 Over 50: Entrepreneurs (2022) for her impactful work in biopharma.2

Personal Motivation

Christi's commitment to her work is deeply personal; she has lost family members to cancer, which fuels her dedication to improving patient outcomes through innovative therapies.23

Overall, Christi Shaw embodies a blend of professional excellence and personal passion, making significant contributions to both her field and her alma mater.